Exagen (XGN) Capital Expenditures Growth (1y) (2019 - 2026)
Exagen (XGN) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -72.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -33.33% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 1.48% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -10.56% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 0.92% |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | 101.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.77% |
| Dec 31, 2025 | 327.40% |
| Sep 30, 2025 | -307.48% |
| Jun 30, 2025 | 53.68% |
| Mar 31, 2025 | 31.40% |
| Dec 31, 2024 | 122.26% |
| Sep 30, 2024 | 7,250.00% |
| Jun 30, 2024 | -58.02% |
| Mar 31, 2024 | -78.28% |
| Dec 31, 2023 | -261.58% |
| Sep 30, 2023 | -99.77% |
| Jun 30, 2023 | -83.35% |
| Mar 31, 2023 | -63.57% |
| Dec 31, 2022 | -26.18% |
| Sep 30, 2022 | 1,897.73% |
| Jun 30, 2022 | 4,040.43% |
| Mar 31, 2022 | 2,370.45% |
| Dec 31, 2021 | -0.54% |
| Sep 30, 2021 | 1,200.00% |
| Jun 30, 2021 | 242.42% |